Gastric cancer in the upper third
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically proven gastric carcinoma in the upper third 2. Performance status 0 and 1 3. Aged 20 to 85 year 4. No history of surgery for gastric cancer (Endoscopic treatment is tolerant) 5. Plt => 100,000/mm3 Creatinine <= 2.0 mg/dl AST <= 200 IU/L ALT <= 200 IU/L T-bil <= 2.0 mg/dl Hb => 8.0 g/dl 6. Patients who gave written informed consent before entry in this study
Exclusion criteria
Exclusion criteria: 1. Ischemic heart disease 2. Liver cirrhosis, active hepatitis 3. Interstitial pneumonia 4. Haemodialysis 5. Both malignant disorder 6. Severe abdominal adhesion 7. Doctor's decision not to register to this regimen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight loss rate 6 months after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical process (operative time, intraoperative bleeding, the number of ports, the use of the saturation, cost, the rates of laparotomy transition), postoperative course (oral intake, length of stay, inflammatory findings, the rates of late complications, stenosis, usage rate of PPI, incidence rate of GERD). | — |
Countries
Japan
Contacts
Wakayama Medical University School of Medicine Second Department of Surgery